Skip to main content
. 2022 Apr 18;13:886428. doi: 10.3389/fmicb.2022.886428

Table 3.

The susceptibility patterns to different antimicrobial agents between non-carbapenemase-producing and carbapenemase-producing carbapenem-resistant E. coli isolates.

Carbapenem-resistant E. coli (%Susceptible)
Antimicrobial agents All (n = 10) Non-CP-CREc
(n = 7)
CP-CREc
(n = 3)
Ceftriaxone 0 0 0
Ceftazidime 0 0 0
Cefepime 0 0 0
Ceftazidime-avibactam 90 100 66.7
Amikacin 90 100 66.7
Gentamicin 20 14.3 33.3
Ciprofloxacin 50 57.1 33.3
Pip/Tazo 0 0 0
TMP/SMX 30 28.6 33.3
Ertapenem 0 0 0
Imipenem 0 0 0

Non-CP-CREc, non-carbapenemase-producing carbapenem-resistant E. coli; CP-CREc, carbapenemase-producing carbapenem-resistant E. coli.